Skip to content

Signal detection in OnePV

One pair stands out

Pharmacovigilance signal detection and management in OnePV: PRR, ROR and EBGM across your data plus FAERS, EVDAS and VAERS, with a recorded decision for every signal.

Signal detection can also run alongside Oracle Argus or ArisGlobal while you plan a move.

A sample signal drawn as a two-by-two table of reports. Exampril with anaphylactic reaction: 12 reports, 2.9 expected. Exampril with all other events: 488. All other products with anaphylactic reaction: 1,450. All other products with all other events: 248,550. Each column stands as tall as its observed-to-expected ratio: the Exampril and anaphylactic reaction column stands at about 4.1, rising through a threshold plane at 2; the other three stand at about 1. PRR 4.1, above the threshold.

Column height: observed ÷ expected reports, with the threshold plane at 2. Sample counts from Northbridge Pharma’s safety database; Exampril and Northbridge Pharma are fictional.

Three methods, one pair

The same four counts, worked three ways.

Sample reports for Exampril and anaphylactic reaction, Northbridge Pharma’s safety database
Anaphylactic reactionAll other events
Examprila12b488
All other productsc1,450d248,550

a + b = 500c + d = 250,000a + c = 1,462N = 250,500

PRRProportional reporting ratio
4.1
a divided by a + b÷c divided by c + d=12 divided by 500÷1,450 divided by 250,000
χ² 25.4 · n 12 · 95% CI 2.4 to 7.3
RORReporting odds ratio
4.2
a × d divided by b × c=12 × 248,550 divided by 488 × 1,450
95% CI 2.4 to 7.5
EBGMEmpirical Bayes geometric mean
O/E4.1
a divided by E=12 divided by 2.9
E = (a + b)(a + c) ÷ N. EBGM pulls this towards 1, with a prior fitted on the whole database.

Sample counts from Northbridge Pharma’s safety database. Thresholds are examples; χ² is Yates-corrected. Exampril and Northbridge Pharma are fictional.

Your data, and the public databases

Detection runs on your own safety database and on three public ones.

Data sources for signal detection
SourceKept byHolds
Your safety databaseYouYour own ICSRs
FAERSFDA Adverse Event Reporting SystemUS Food and Drug AdministrationAdverse event and medication error reports for drugs and therapeutic biologics
EVDASEudraVigilance Data Analysis SystemEuropean Medicines AgencyReports of suspected adverse reactions held in EudraVigilance, for medicines authorised in the EEA
VAERSVaccine Adverse Event Reporting SystemUS CDC and FDAReports of adverse events after vaccination

Some events need only one report

Rules flag designated medical events, SUSARs, events of interest and your own criteria, without waiting for a ratio.

Designated medical events
Rare, serious events that justify review even from a single report. The EMA publishes the list.
SUSARs
Suspected unexpected serious adverse reactions reported from your clinical trials.
Events of interest
The events you have chosen to watch for each product.
Your own rules
Criteria you define, by product, by event or both.

Each match opens for review with its cases, in an ICSR view and a timeline view.

From detection to a recorded decision

The sample signal, step by step: who did each step and what was recorded. The steps are those of GVP Module IX, less signal confirmation, which the regulators carry out.

The sample signal for Exampril and anaphylactic reaction, from detection to a recorded decision
StepByRecorded
Signal detectionDetection runPRR 4.1 for Exampril and anaphylactic reaction, above the threshold
Signal validationSignal analystThe 12 reports reviewed against the source data; signal validated
Analysis and prioritisationSafety physicianSerious event: high priority
Signal assessmentSafety physicianCase series and published literature assessed
Recommendation for actionSafety review committeeUpdate the reference safety information. Decision recorded and signed

Sample signal. Exampril is fictional.

Audit trailEvery field change is versioned and attributable, with e-signature where required.

ValidationBuilt for 21 CFR Part 11 and EU Annex 11. IQ/OQ/PQ validation is part of every engagement.

Also in OnePV

  • Case intake

    Email, web forms, call centre (MICC) and partner reports in one triage queue.

  • Safety database

    ICSR processing, MedDRA and WHODrug coding, narratives, quality and medical review.

  • Literature management

    PubMed and Embase articles are screened, and relevant ones become cases inside the safety workflow.

  • PV agreements (SDEA)

    The safety data exchange agreements your partners report under.

One system for patients, medical devices, cosmetics and veterinary medicines.

Bring a pair you are watching

Anonymised or made up. We will take it from detection to a recorded decision with you.

hello@clinevotech.com+91 98201 03201